Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
SURG's Cash to Debt is ranked higher than
100% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SURG: No Debt )
SURG' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.75
SURG's Equity to Asset is ranked higher than
80% of the 450 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SURG: 0.75 )
SURG' s 10-Year Equity to Asset Range
Min: 0.57   Max: 0.98
Current: 0.75

0.57
0.98
Interest Coverage No Debt
SURG's Interest Coverage is ranked higher than
74% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. SURG: No Debt )
SURG' s 10-Year Interest Coverage Range
Min: 1.56   Max: 9999.99
Current: No Debt

1.56
9999.99
F-Score: 6
Z-Score: 5.25
M-Score: -3.00
WACC vs ROIC
9.83%
6.02%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 6.60
SURG's Operating margin (%) is ranked higher than
77% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 5.50 vs. SURG: 6.60 )
SURG' s 10-Year Operating margin (%) Range
Min: -8.11   Max: 15
Current: 6.6

-8.11
15
Net-margin (%) 4.40
SURG's Net-margin (%) is ranked higher than
75% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. SURG: 4.40 )
SURG' s 10-Year Net-margin (%) Range
Min: -7.41   Max: 11.01
Current: 4.4

-7.41
11.01
ROE (%) 4.59
SURG's ROE (%) is ranked higher than
72% of the 449 Companies
in the Global Medical Devices industry.

( Industry Median: 5.02 vs. SURG: 4.59 )
SURG' s 10-Year ROE (%) Range
Min: -2.53   Max: 16.86
Current: 4.59

-2.53
16.86
ROA (%) 3.44
SURG's ROA (%) is ranked higher than
75% of the 481 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. SURG: 3.44 )
SURG' s 10-Year ROA (%) Range
Min: -2.44   Max: 11.03
Current: 3.44

-2.44
11.03
ROC (Joel Greenblatt) (%) 12.82
SURG's ROC (Joel Greenblatt) (%) is ranked higher than
78% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 6.67 vs. SURG: 12.82 )
SURG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -13.95   Max: 40.77
Current: 12.82

-13.95
40.77
Revenue Growth (3Y)(%) 4.70
SURG's Revenue Growth (3Y)(%) is ranked higher than
74% of the 344 Companies
in the Global Medical Devices industry.

( Industry Median: 4.90 vs. SURG: 4.70 )
SURG' s 10-Year Revenue Growth (3Y)(%) Range
Min: -2.6   Max: 50.6
Current: 4.7

-2.6
50.6
EBITDA Growth (3Y)(%) -13.40
SURG's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. SURG: -13.40 )
SURG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 115.4
Current: -13.4

0
115.4
EPS Growth (3Y)(%) -19.50
SURG's EPS Growth (3Y)(%) is ranked higher than
66% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. SURG: -19.50 )
SURG' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 122.4
Current: -19.5

0
122.4
» SURG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

SURG Guru Trades in Q1 2014

Chuck Royce 1,491,274 sh (+51.97%)
Jim Simons 52,400 sh (+3.35%)
» More
Q2 2014

SURG Guru Trades in Q2 2014

Jim Simons 79,500 sh (+51.72%)
Chuck Royce 1,531,149 sh (+2.67%)
» More
Q3 2014

SURG Guru Trades in Q3 2014

Jim Simons 153,400 sh (+92.96%)
Chuck Royce 1,531,149 sh (unchged)
» More
Q4 2014

SURG Guru Trades in Q4 2014

Jim Simons 211,600 sh (+37.94%)
Chuck Royce 1,166,874 sh (-23.79%)
» More
» Details

Insider Trades

Latest Guru Trades with SURG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 39.00
SURG's P/E(ttm) is ranked higher than
82% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 120.60 vs. SURG: 39.00 )
SURG' s 10-Year P/E(ttm) Range
Min: 5.03   Max: 335.63
Current: 39

5.03
335.63
Forward P/E 19.38
SURG's Forward P/E is ranked higher than
91% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 19.38 )
N/A
PE(NRI) 37.70
SURG's PE(NRI) is ranked higher than
82% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 94.20 vs. SURG: 37.70 )
SURG' s 10-Year PE(NRI) Range
Min: 5   Max: 335.63
Current: 37.7

5
335.63
P/B 1.77
SURG's P/B is ranked higher than
87% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 4.16 vs. SURG: 1.77 )
SURG' s 10-Year P/B Range
Min: 0.49   Max: 9.59
Current: 1.77

0.49
9.59
P/S 1.73
SURG's P/S is ranked higher than
83% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 3.75 vs. SURG: 1.73 )
SURG' s 10-Year P/S Range
Min: 0.34   Max: 7.18
Current: 1.73

0.34
7.18
PFCF 13.70
SURG's PFCF is ranked higher than
96% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 13.70 )
SURG' s 10-Year PFCF Range
Min: 1.6   Max: 99999999.99
Current: 13.7

1.6
99999999.99
POCF 11.89
SURG's POCF is ranked higher than
92% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 74.13 vs. SURG: 11.89 )
SURG' s 10-Year POCF Range
Min: 1.54   Max: 99999999.99
Current: 11.89

1.54
99999999.99
EV-to-EBIT 21.71
SURG's EV-to-EBIT is ranked higher than
85% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 68.02 vs. SURG: 21.71 )
SURG' s 10-Year EV-to-EBIT Range
Min: -796.9   Max: 153.4
Current: 21.71

-796.9
153.4
Shiller P/E 26.58
SURG's Shiller P/E is ranked higher than
93% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 26.58 )
SURG' s 10-Year Shiller P/E Range
Min: 8   Max: 255
Current: 26.58

8
255
Current Ratio 5.71
SURG's Current Ratio is ranked higher than
88% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 2.58 vs. SURG: 5.71 )
SURG' s 10-Year Current Ratio Range
Min: 1.73   Max: 30
Current: 5.71

1.73
30
Quick Ratio 4.01
SURG's Quick Ratio is ranked higher than
84% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. SURG: 4.01 )
SURG' s 10-Year Quick Ratio Range
Min: 0.68   Max: 14
Current: 4.01

0.68
14
Days Inventory 196.21
SURG's Days Inventory is ranked higher than
64% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 157.38 vs. SURG: 196.21 )
SURG' s 10-Year Days Inventory Range
Min: 122.69   Max: 332.79
Current: 196.21

122.69
332.79
Days Sales Outstanding 67.22
SURG's Days Sales Outstanding is ranked higher than
78% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 78.80 vs. SURG: 67.22 )
SURG' s 10-Year Days Sales Outstanding Range
Min: 24.57   Max: 96.62
Current: 67.22

24.57
96.62

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 7.54
SURG's Price/Net Current Asset Value is ranked higher than
91% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 7.54 )
SURG' s 10-Year Price/Net Current Asset Value Range
Min: 3.53   Max: 127.5
Current: 7.54

3.53
127.5
Price/Tangible Book 2.94
SURG's Price/Tangible Book is ranked higher than
84% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 6.96 vs. SURG: 2.94 )
SURG' s 10-Year Price/Tangible Book Range
Min: 1.84   Max: 19.65
Current: 2.94

1.84
19.65
Price/DCF (Projected) 1.03
SURG's Price/DCF (Projected) is ranked higher than
97% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 1.03 )
SURG' s 10-Year Price/DCF (Projected) Range
Min: 0.73   Max: 23.44
Current: 1.03

0.73
23.44
Price/Median PS Value 0.90
SURG's Price/Median PS Value is ranked higher than
87% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 1.36 vs. SURG: 0.90 )
SURG' s 10-Year Price/Median PS Value Range
Min: 0.23   Max: 5.11
Current: 0.9

0.23
5.11
Price/Graham Number 2.27
SURG's Price/Graham Number is ranked higher than
88% of the 523 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 2.27 )
SURG' s 10-Year Price/Graham Number Range
Min: 0.82   Max: 14.29
Current: 2.27

0.82
14.29
Earnings Yield (Greenblatt) 4.60
SURG's Earnings Yield (Greenblatt) is ranked higher than
85% of the 476 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. SURG: 4.60 )
SURG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 18.4
Current: 4.6

0.7
18.4
Forward Rate of Return (Yacktman) -5.74
SURG's Forward Rate of Return (Yacktman) is ranked higher than
65% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 5.08 vs. SURG: -5.74 )
SURG' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -9.6   Max: 1024
Current: -5.74

-9.6
1024

Analyst Estimate

Jul15 Jul16
Revenue(Mil) 74 85
EPS($) 0.16 0.23
EPS without NRI($) 0.16 0.23

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Synergetics USA Inc is a Delaware corporation incorporated on June 2, 2005 in connection with the reverse merger of Synergetics, Inc. and Valley Forge Scientific Corp. The Company is a supplier of precision surgical devices. It develops, manufactures, and markets disposable and durable equipment for use in ophthalmologic, neurosurgical, and other microsurgical applications. The Company's product lines focus upon precision engineered, disposable and reusable devices, procedural kits and the delivery of various energy modalities for the performance of surgery, including: laser energy, ultrasonic energy, radio frequency energy for electrosurgery and lesion generation and visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. It's ophthalmic and vitreoretinal surgical devices and equipment compete against manufacturers of similar products, including those sold by its major competitors, Alcon, Bausch & Lomb, Inc., Dutch Ophthalmic Research Center and Iridex. The Company is subject to macro-economic fluctuations in the United States, the countries of Europe and the economies of other countries throughout the world. Medical device companies are subject to rigorous regulation, including by the FDA and numerous other federal, state and foreign governmental authorities.
» More Articles for SURG

Headlines

Articles On GuruFocus.com
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2015 Results Dec 01 2014 
Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2014 Results Oct 15 2014 
Synergetics USA: A Growth Story Amidst an Aging Population Aug 30 2012 
Synergetics Up 30% after Approval for Eye Surgery Device Jun 28 2012 
Synergetics USA Inc. (SURG) EVP & COO Kurt W Jr Gampp sells 43,000 Shares Mar 15 2011 
Weekly CFO Buys Highlight: CNLG, SIFID, FUL, SURG, TYL Jan 15 2011 
Synergetics USA Inc. (SURG) President and CEO David M Hable sells 17,000 Shares Jan 07 2011 
Weekly CFO Buys Highlight: COIN, INTC, SURG, IBCA, AUMN Oct 24 2010 
Synergetics USA, Inc. Announces 3 Month Extension of Current Agreements with Codman & Shurtleff, Inc Jan 07 2009 

More From Other Websites
Second Sight's 30% Jump Boosts Several Peers Feb 25 2015
Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2015 Results Feb 24 2015
Allscripts Sunrise EHR: IHMC's Choice for Flagship Hospital - Analyst Blog Feb 13 2015
Bioanalytical Systems' Breakeven Q1 Earnings, Down Y/Y - Analyst Blog Feb 13 2015
Alere (ALR) Disappoints; Misses on Earnings, Revenues in Q4 - Analyst Blog Feb 13 2015
Acadia Healthcare Posts In-Line Q4 Earnings, Revenue Beat - Analyst Blog Feb 12 2015
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog Feb 06 2015
Affymetrix (AFFX) Earnings, Revenues Outshine Estimates - Analyst Blog Feb 05 2015
Techne Q2 Earnings, Revenues Miss Estimates but Grow Y/Y - Analyst Blog Feb 04 2015
Pacific Biosciences Posts Q4 Loss as Expected, Shares Fall - Analyst Blog Feb 04 2015
Intuitive Surgical Announces $1B Share Buyback Program - Analyst Blog Feb 03 2015
Wright Medical (WMGI) Gets Second Request from FTC - Analyst Blog Feb 03 2015
Cerner (CERN) Acquires Siemens Health Services Operations - Analyst Blog Feb 03 2015
Luminex (LMNX) Q4 Earnings Top, Revenues Meet Estimates - Analyst Blog Feb 03 2015
Luminex Gets Health Canada Approval for Genotyping Assay - Analyst Blog Feb 02 2015
Abiomed: A Strong Buy on Impressive Q3, Estimate Revision - Analyst Blog Feb 02 2015
AngioDynamics Celerity System Gets Expanded FDA Approval - Analyst Blog Jan 30 2015
FDA OKs DexCom Glucose Monitoring System with Share App - Analyst Blog Jan 28 2015
Abiomed Q3 Earnings Impress; Impella RP Gets FDA Approval - Analyst Blog Jan 28 2015
Accuray (ARAY) Q2 Loss Wider than Expected, Revenues Lag - Analyst Blog Jan 28 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK